ArticleScientific reports2026
Evaluation of an ultraviolet C device for hospital pharmacy compounding.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aseptic pharmaceutical compounding is a high-risk activity in hospital pharmacies requiring strict environmental control. Ultraviolet-C (UVC) irradiation offers a "non-touch" and chemical-free method of disinfection for materials entering in white rooms. The present study aimed to investigate the efficacy of a UVC disinfection device (Artemisia, Byola, Faulquemont, France) for inactivating common hospital pathogens in vitro. Stock solutions of Staphylococcus aureus, Bacillus spizizenii, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans were prepared and spread on Petri dishes. Plates were placed in the disinfection device and exposed to UVC for 1, 2, 3, 4, and 5 min (2, 5, and 10 min for B. spizizenii). After UVC exposure, culture plates were incubated at 32 ± 2 °C and colony forming unit were quantified 24- and 120-hours post-exposure. Microorganisms were chosen as they have different cell wall compositions and are associated with healthcare-associated infections; B. spizizenii spores were included as a surrogate microorganism for pathogenic spore species and strains. For all microorganisms, after 2 min of exposure a reduction > 7 log
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.